drugset
drugset / Trial / NCT03698045

Safety and Tolerability of PRO-143 Ophthalmic Solution in Healthy Volunteers.

NCT03698045 ↗

Phase 1 Withdrawn Laboratorios Sophia S.A de C.V.
NaSingle-groupOpen-labelTreatment

Summary

Study to evaluate the safety and tolerability of PRO-143 solution ophthalmic in healthy volunteers.

Timeline

Start
2013-11
Primary completion
2014-02
Completion
2014-03

Outcome

Outcome not reported

Stopped: “the clinical study was canceled by the sponsor due to logistics and programming”

Drugs

EvaluationDrugModalityDoseRoute
Subject PRO-143 Unknown — Other

Indications

bacterial conjunctivitis